SomniSupport

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Humulus lupulus, Quantity: 125 mg (Equivalent: Humulus lupulus, Qty 500 mg); Medicago sativa, Quantity: 85 mg (Equivalent: Medicago sativa, Qty 7.65 g); Oryza sativa, Quantity: 5 mg (Equivalent: Oryza sativa, Qty 450 mg)

Available from:

Factors Group Australia Pty Ltd

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; Chlorella pyrenoidosa; croscarmellose sodium; magnesium stearate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support general health and wellbeing ; Decrease/reduce/relieve restlessness/excess nervous energy ; Decrease/reduce/relieve nervous tension/unrest ; Decrease/reduce/relieve symptoms of mild anxiety ; Traditionally used in Western herbal medicine to Calmative/nervous system relaxant ; Enhance/promote/increase refreshing sleep ; Decrease/reduce/relieve sleeplessness ; Decrease/reduce time to fall asleep ; Decrease/reduce/relieve disturbed/restless sleep

Product summary:

Visual Identification: ; Container Type: Bottle

Authorization status:

Listed

Authorization date:

2019-08-19